Peptide Bioavailability: Why Route of Administration Changes Research

Bioavailability refers to the proportion of an administered substance that reaches systemic circulation in a measurable form. Many peptides face challenges when taken orally because digestive enzymes can break them down and intestinal barriers limit absorption. Researchers investigate protective formulations and alternative delivery technologies, but success varies greatly by molecule. A promising laboratory absorption result is not the same as proven effectiveness in people. Comparisons between studies require attention to route, formulation, population and measurement technique. No delivery approach should be assumed safe merely because it is innovative.